Cite
HARVARD Citation
Lipton, R. et al. (n.d.). P.029 Oral Daily Atogepant for the Preventive Treatment of Migraine Increases Responder Rates for Reduction in Mean Monthly Migraine Days. Canadian journal of neurological sciences. p. S28. [Online].